Myriad Genetics, a prominent molecular diagnostic testing firm, has successfully revamped its artificial intelligence framework, dramatically cutting down the time required for processing critical documents. This initiative, undertaken in collaboration with Amazon Web Services (AWS), has transformed the company's revenue cycle management, shifting from a process that could take months to one that now operates in mere seconds. The core of this transformation lies in an enhanced AI tool capable of automating the classification, extraction, and overall handling of diagnostic, insurance, and reimbursement paperwork, thereby significantly accelerating cash flow and operational efficiency.
Initially, Myriad Genetics developed an in-house AI solution, named Image Genius, to tackle the extensive paperwork associated with its 1.5 million annual diagnostic tests. While this initial version showed promise in automating document tasks and extracting vital information, it soon became apparent that its operational costs were unsustainable and its processing times, though improved, were still not optimal. Recognizing these limitations, Myriad sought external expertise, leading to a pivotal partnership with AWS. This collaboration enabled the integration of advanced generative AI capabilities, paving the way for a more cost-effective and highly efficient system that now processes documents in a fraction of the time previously required, profoundly impacting the company's financial and administrative workflows.
The Evolution of Myriad's AI Document Processing
Myriad Genetics embarked on an ambitious journey to modernize its document handling, driven by the need to streamline the complex revenue cycle management inherent in processing vast numbers of diagnostic tests. Initially, the company's internal AI solution aimed to classify pathology reports, tag documents, and extract crucial information, particularly for Medicare claims. This first iteration, named Image Genius, leveraged Amazon Textract and Comprehend to automate various tasks, including the processing of insurance cards and reduction of manual intervention. The goal was to expedite prior authorizations, a critical step often required within days or hours of sample collection to ensure insurance coverage and prevent delays in patient care or revenue loss.
The initial deployment of Image Genius in Myriad's hereditary cancer division marked a significant step towards automating medical document classification and refining revenue cycle workflows. However, scaling this system proved challenging due to high maintenance costs, prolonged processing times, and difficulties in accurately distinguishing between different types of medical documents, such as testing orders and doctor's notes. Recognizing these hurdles, Myriad strategically shifted its approach in late 2024, leading to a collaboration with the AWS Generative AI Innovation Center. This partnership was instrumental in rebuilding Image Genius on Amazon Bedrock, which allowed Myriad to experiment with various foundational models, ultimately selecting the most effective combination for speed, accuracy, and cost-efficiency, thus laying the groundwork for a more robust and sustainable AI infrastructure.
Achieving Unprecedented Efficiency and Cost Savings
The collaborative efforts between Myriad Genetics and AWS culminated in the successful relaunch of the re-engineered Image Genius platform in the first quarter of 2026. This advanced system, built on Amazon Bedrock and utilizing Amazon Nova's AI models, marked a significant leap forward in processing efficiency. The enhanced platform drastically cut the average document processing time from 10 minutes to a mere 20 seconds, directly contributing to accelerated repayment cycles and improved cash flow for Myriad. This dramatic reduction in processing time is particularly critical given that healthcare companies often face up to 18 months to receive full reimbursement for testing orders due to the intricate nature of insurance claims and medical billing.
The tangible benefits of the revamped Image Genius are already evident. Within Myriad's women's health division, the new tool has saved approximately 300 staff hours per month across some 9,000 prior authorizations. This remarkable efficiency gain not only optimizes resource allocation but also enhances the speed and accuracy of critical administrative tasks. Looking ahead, Myriad plans to extend the deployment of Image Genius to its oncology and mental health units by 2027, further integrating AI and automation across all facets of the revenue cycle. Under the leadership of its new CTO, Raj Jampa, the company is focused on leveraging these AI capabilities to improve eligibility verification, claims submission, denial management, and appeals handling, reinforcing its commitment to operational excellence and patient care through cutting-edge technology.
